GlassScriptPhysician profile
Jonathan T Matthews
NPI 1699242438
$4,425.32
in general payments reported to CMS, 2019-2025
11 companies · $2,924 in 2025
The $2,924 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.56 · 2022: $25.92 · 2023: $1,373 · 2024: $39.11 · 2025: $2,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,492 · Food and Beverage: $820 · Gift: $23.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,491.55 |
| Food and Beverage | $820.44 |
| Gift | $23.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $2,782.31 | 2025 | Inset System |
| Fx Shoulder Solutions, INC | $1,255.77 | 2023 | |
| Bioventus LLC | $132.89 | 2022-2024 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $69.13 | 2025 | |
| Pacira Therapeutics, INC. | $43.56 | 2021 | |
| Pylant Medical | $30.43 | 2025 | |
| Kci USA, INC. | $26.35 | 2023 | Prevena Restor Arthroform, Prevena |
| Heron Therapeutics, INC. | $23.32 | 2025 | Zynrelef |
| Fidia Pharma USA INC. | $22.54 | 2024 | Hymovis, Triluron, Hyalgan |
| Sanofi-Aventis U.S. LLC | $20.00 | 2021 | |
| Depuy Synthes Sales INC. | $19.02 | 2025 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.